SURGE Therapeutics

Developer of a proprietary technology-based platform intended to provide immunotherapy. The company's platform offers an injectable biodegradable hydrogel that allows prolonged, localized free-up of cancer immunotherapy on the web page of surgical tumor resection by focusing the dose at the right place and at the right time, enabling patients to receive treatment via intravenous or even intratumoral injection.

Khosla Ventures

8VC

🏥 Healthcare